High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-a-treated psoriasis patients

Journal of Investigative Dermatology

Volumn 120, Issue 4, 2003, Pages 676-682

  Kreimer Erlacher, Heidemarie ^a   Seidl, Hannes ^a   Bäck, Barbara ^a   Cerroni, Lorenzo ^a   Kerl, Helmut ^a   Wolf, Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Carcinogenesis; Ha ras; Mutagenesis; P53; Skin cancer

Indexed keywords

3' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; DNA POLYMORPHISM; DNA SEQUENCE; EXON; FEMALE; GENE LOCUS; GENE MUTATION; HUMAN; INTRON; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE; PSORIASIS; PUVA; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ULTRAVIOLET B RADIATION;

EID: 0037377686     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12085.x     Document Type: Article

References (52)

1. Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N: CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 91:446-452, 1999
2. Ananthaswamy H: Neoplastic transformation of C3H mouse embryo 10T1/2 cells by 8-methoxypsoralen plus UVA radiation. J Invest Dermatol 85:102-106, 1985
3. Boyer V, Moustacchi E, Sage E: Sequence specificity in photoreaction of various psoralen derivatives with DNA: role in biological activity Biochem 27:3011-3018, 1988
4. Brash DE, Rudolph JA, Simon JA, et al: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 90:10124-10128, 1991
5. Campbell C, Quinn A, Rees J: Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer. Br J Dermatol 128:111-114, 1992
6. Chiou C, Yang J: Mutagenicity and specific mutation spectrum induced by 8-methoxypsoralen plus low dose of UVA in the hprt gene in diploid human fibroblasts. Carcinogen 16:1357-1362, 1995
7. Cooper D, Krawczak M: Human Gene Mutation. Oxford: BIOS Scientific, 1993
8. Fargnoli M, Chimenti S, Keller G, Soyer H, Pozzo V, Höfler H, Peris K: CDKN2a/ p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. J Invest Dermatol 111:1202-1206, 1998
9. FitzGerald M, Harkin D, Silva-Arrieta S, et al: Prevalence of germline mutations in p16, p19 ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci USA 93:8541-8545, 1996
10. Goldstein A, Struewing J, Chidambaram A, Fraser M, Tucker M: Genotypephenotype relationships families with CDKN2A and CDK4 mutations. J Natl Cancer Inst 92:1006-1010, 2000
11. Griffin AC: Methoxalen in ultraviolet carcinogenesis in the mouse. J Invest Dermatol 32:367-372, 1959
12. Gunther EJ, Yeasky TM, Gasparro FP, Glazer PM: Mutagenesis by 8-methoxypsoralen and 5-methylangelicin photoadducts in mouse fibroblasts: mutations at cross-linkable sites induced by monoadducts as well as cross-links. Cancer Res 55:1283-1288, 1995
13. Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J: CDKN2A germline mutations in individuals with multiple cutaneous melanomas. Cancer Res 60:6864-6867, 2000
14. Holland E, Schmid H, Kefford R, Mann GJ: CDKN2A (P16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas. Genes Chrom Cancer 25:339-348, 1999
15. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML, Ananthaswamy HN: High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: Evidence for strand bias and minor heterogeneity. Cancer Res 53:2961-2964, 1993
16. Kreimer-Erlacher H, Seidl H, Bäck B, Kerl H, Wolf P: High mutation frequency at Ha-ras exon 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients. Photochem Photobiol 74:323-330, 2001
17. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwartz M: Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res 52:6400-6403, 1992
18. Kripke ML, Morison WL, Parrish JA: Induction and transplantation of murine skin cancers induced by methoxalen plus ultraviolet (320-400 nm) radiation. J Natl Cancer Inst 68:685-690, 1982
19. Kripke ML, Morison WL, Parrish JA: Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol 81:87-92, 1983
20. Kubo Y, Urano Y, Yoshimoto K, Iwahana H, Fukuhara K, Arase S, Itakura M: p53 gene mutations in human skin cancers and precancerous lesions: Comparison with immunohistochemical analysis. J Invest Dermatol 102:440-444, 1994
21. Kubo Y, Urano Y, Matsumoto K, Ahsan K, Arase S: Mutations of the INK4a locus in squamous cell carcinomas of human skin. Biochem Biophys Res Commun 232:38-41, 1997
22. Laird P, Jaenisch R: The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 30:441-464, 1996
23. MacKie R, Andrew N, Lanyon W, Connor J: CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. J Invest Dermatol 111:269-272, 1998
24. Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H: Skin tumors in photochemotherapy for psoriasis. A single-center follow-up of 496 patients. Dermatology 193:185-191, 1996
25. Moles JP, Moyret C, Guillot B, Jeanteur B, Guilhou J, Theillet C, Basset-Seguin N: p53 gene mutations in human epithelial skin cancers. Oncogene 8:583-588, 1993
26. Nakazawa H, English D, Randell P, Nakazawa K, Martel N, Armstrong B, Yamasaki H: UV and skin cancer: Specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 91:360-364, 1994
27. Nataraj AJ, Trent JC, Ananthaswamy HN: p53 mutations and photocarcinogenesis. Photochem Photobiol 62:218-230, 1995
28. Nataraj AJ, Black HS, Ananthaswamy HN: Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA) -induced murine skin cancers. Proc Natl Acad Sci USA 93:7961-7965, 1996
29. Nataraj A, Wolf P, Cerroni L, Ananthaswamy H: p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA). J Invest Dermatol 109:238-243, 1997
30. Nelson MA, Einspar JG, Alberts DS, Balfour CA: Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85:23-29, 1994
31. Pathak MA, Daniels F. Hopkins CE, Fitzpatrick TB: Ultraviolet carcinogenesis in albino and pigmented mice receiving furocoumarins, psoralen and 8-methoxypsoralen. Nature 183:728-739, 1959
32. Perera F: Environment and cancer: Who are susceptible? Science 278:1068-1073, 1997
33. ARF mutations in sporadic melanomas. J Invest Dermatol 113:825-826, 1999
34. Rady P, Scinicariello F, Wagner R, Tyring S: p53 mutations in basal cell carcinomas. Cancer Res 52:3804-3806, 1992
35. Ren Z, Hedrum A, Ponten F, et al: Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 12:765-773, 1996
36. Sage E, Bredberg A: Damage distribution and mutation spectrum: The case of 8-methoxypsoralen plus UV-A in mammalian cells. Mutat Res 263:217-222, 1991
37. Sage E, Moustacchi E: Sequence context effects on 8-methoxypsoralen photobinding to defined DNA fragments. Biochemistry 26:3307-3314, 1987
38. Sage E, Dobretsky E, Moustacchi E: 8-Methoxypsoralen induced mutations are highly targeted at crosslinkable sites of photoaddition on the non-transcribed strand of a mammalian chromosomal gene. EMBO J 12:397-402, 1993
39. Seidl H, Kreimer-Erlacher H, Bäck B, Soyer HP, Höfler G, Kerl H, Wolf P: Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J Invest Dermatol 117:365-370, 2001
40. Soufir N, Molès J, Vilmer C, et al: 16 UV mutations in human skin epithelial tumors. Oncogene 18:5477-5481, 1999
41. Soufir N, Daya-Grosjean L, De la Salmonière P, Moles J, Dubertret L, Sarasin A, Basset-Seguin N: Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst 92:1841-1847, 2000
42. Stern RS, Liebman EJ, Vakeva L: Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. The PUVA follow-up study. J Natl Cancer Inst 90:1278-1284, 1998
43. Stott F, Bates S, James M, et al: The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17:5001-5014, 1998
44. Strauss G, Bridges B, Greaves M, Hall-Smith P, Price M, Vella-Briffa D: Inhibition of delayed hypersensitivity reaction in skin (DNCB test) by 8-methoxypsoralen photochemotherap: possible basis for pseudo-promoting action in skin carcinogenesis? Lancet. II:556-559, 1980
45. Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG: Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol 136:1118-1122, 2000
46. Vogel F, Kopun M: Higher frequencies of transitions among point mutations. J Mol Evol 9:159, 1977
47. Walker G, Hussussian C, Flores J, et al: Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum Mol Gen 4:1845-1852, 1995
48. Walker G, Gabrielli B, Castellano M, Hayward N: Functional reasessment of P16 variants using a transfection-based assay. Int J Cancer 82:305-312, 1999
49. Wang X, McNiff J, Klump V, Asgari M, Gasparro F: An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA. Photochem Photobiol 66:294-299, 1997
50. Yang S, Lin J, Chiou C, Chen L, Yang J: Mutation specificity of 8-methoxypsoralen plus two doses of UVA irradiation in the hprt gene in diploid human fibroblasts. Carcinogen 15:201-207, 1994
51. Ziegler A, Leffell DJ, Kunala S, et al: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90:4216-4220, 1993
52. Ziegler A, Jonason A, Lefell D, et al: Sunburn and p53 in the onset of skin cancer. Nature 372:773-776, 1994